JP2025510017A5 - - Google Patents

Info

Publication number
JP2025510017A5
JP2025510017A5 JP2024555349A JP2024555349A JP2025510017A5 JP 2025510017 A5 JP2025510017 A5 JP 2025510017A5 JP 2024555349 A JP2024555349 A JP 2024555349A JP 2024555349 A JP2024555349 A JP 2024555349A JP 2025510017 A5 JP2025510017 A5 JP 2025510017A5
Authority
JP
Japan
Prior art keywords
seq
aav vector
recombinant aav
nos
signal peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024555349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510017A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/015531 external-priority patent/WO2023177885A2/en
Publication of JP2025510017A publication Critical patent/JP2025510017A/ja
Publication of JP2025510017A5 publication Critical patent/JP2025510017A5/ja
Pending legal-status Critical Current

Links

JP2024555349A 2022-03-18 2023-03-17 シグナルペプチド改変を有する、ポンペ病を処置するためのアルファ-グルコシダーゼ(gaa)をコードするコドン最適化核酸を使用する治療用アデノ随伴ウイルス Pending JP2025510017A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263321336P 2022-03-18 2022-03-18
US63/321,336 2022-03-18
US202263348862P 2022-06-03 2022-06-03
US63/348,862 2022-06-03
US202363444804P 2023-02-10 2023-02-10
US63/444,804 2023-02-10
PCT/US2023/015531 WO2023177885A2 (en) 2022-03-18 2023-03-17 Therapeutic adeno-associated virus using codon optimized nucleic acid encoding alpha-glucosidase (gaa) for treating pompe disease, with signal peptide modifications

Publications (2)

Publication Number Publication Date
JP2025510017A JP2025510017A (ja) 2025-04-14
JP2025510017A5 true JP2025510017A5 (cg-RX-API-DMAC7.html) 2026-03-26

Family

ID=88024211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024555349A Pending JP2025510017A (ja) 2022-03-18 2023-03-17 シグナルペプチド改変を有する、ポンペ病を処置するためのアルファ-グルコシダーゼ(gaa)をコードするコドン最適化核酸を使用する治療用アデノ随伴ウイルス

Country Status (11)

Country Link
US (1) US20250213726A1 (cg-RX-API-DMAC7.html)
EP (1) EP4493704A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025510017A (cg-RX-API-DMAC7.html)
KR (1) KR20250005569A (cg-RX-API-DMAC7.html)
CN (1) CN119213137A (cg-RX-API-DMAC7.html)
AU (1) AU2023235203A1 (cg-RX-API-DMAC7.html)
CA (1) CA3254578A1 (cg-RX-API-DMAC7.html)
IL (1) IL315711A (cg-RX-API-DMAC7.html)
MX (1) MX2024011396A (cg-RX-API-DMAC7.html)
TW (1) TW202403048A (cg-RX-API-DMAC7.html)
WO (1) WO2023177885A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3252501A1 (en) * 2022-02-25 2023-08-31 AskBio Inc. Adeno-associated virus therapy for the treatment of Pompe disease with long-term cessation of GAA enzymatic replacement therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1587923E (pt) * 2003-01-22 2011-12-07 Univ Duke Construções melhoradas para a expressão de polipéptidos lisossomais
EP3293259A1 (en) * 2016-09-12 2018-03-14 Genethon Acid-alpha glucosidase variants and uses thereof
WO2020102645A1 (en) * 2018-11-16 2020-05-22 Asklepios Biopharmaceutical, Inc. Therapeutic adeno-associated virus for treating pompe disease
CA3120087A1 (en) * 2018-11-16 2020-05-22 Asklepios Biopharmaceutical, Inc. Vectors comprising a nucleic acid encoding lysosomal enzymes fused to a lysosomal targeting sequence
WO2021102107A1 (en) * 2019-11-19 2021-05-27 Asklepios Biopharmaceutical, Inc. Therapeutic adeno-associated virus comprising liver-specific promoters for treating pompe disease and lysosomal disorders

Similar Documents

Publication Publication Date Title
JP2023503046A5 (cg-RX-API-DMAC7.html)
TWI920044B (zh) 用於治療龐貝症及溶酶體病症之包含肝特異性啟動子之治療性腺相關病毒
US20230048025A1 (en) Adeno associated viral vectors
JP2023503637A5 (cg-RX-API-DMAC7.html)
CN113316639A (zh) 用于治疗庞贝氏病的治疗性腺相关病毒
IL299325B1 (en) Variants of acid alpha-glucosidase and their uses
JP2024523707A5 (cg-RX-API-DMAC7.html)
JP2022520232A5 (cg-RX-API-DMAC7.html)
JP2022504740A5 (cg-RX-API-DMAC7.html)
JP7654562B2 (ja) 線維芽細胞増殖因子23関連低リン血症性疾患の遺伝子療法
WO2023060269A4 (en) Recombinant adeno-associated viruses for targeted delivery
JP2021533805A5 (cg-RX-API-DMAC7.html)
JP2022513308A5 (cg-RX-API-DMAC7.html)
JP2022531861A5 (cg-RX-API-DMAC7.html)
JP2022511453A5 (cg-RX-API-DMAC7.html)
CA3151442A1 (en) Sortilin receptor ligand based chimeric polypeptides and uses thereof
CN114829391A (zh) 用肝特异性基因疗法载体治疗遗传性血管性水肿
IL315711A (en) Therapeutic adeno-associated virus using codon optimized nucleic acid encoding alpha-glucosidase (gaa) for treating pompe disease, with signal peptide modifications
JP2025508841A5 (cg-RX-API-DMAC7.html)
CN119173269A (zh) 用于递送glp-1受体激动剂融合物的aav载体
JP7745307B2 (ja) 連結ペプチド、連結ペプチドを含む血液凝固viii因子タンパク質又はその変異体及びその用途
JP2025504478A5 (cg-RX-API-DMAC7.html)
CN107073078A (zh) 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物
KR20240049295A (ko) 방사선 유발 타액 기능저하를 예방하기 위한 aqp1 유전자 요법
WO2021078834A1 (en) Chimeric acid-alpha glucosidase polypeptides and uses thereof